Finance

Lists
300147:SHE
Xiangxue Pharmaceutical Co Ltd
5,14 CNY
-1,34%
(-0,070) 1D
16 ოქტ, 15:04:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300147...
Open
5,11 CNY
High
5,30 CNY
Low
5,10 CNY
Mkt. cap
3,45 მლრდ.
Avg. vol.
10,62 მლნ.
Volume
8,21 მლნ.
52-wk high
11,23 CNY
52-wk low
5,03 CNY
EPS
-2,16 CNY
Shares outstanding
661,28 მლნ.
No. of employees
3 ათ.
Open
5,11 CNY
High
5,30 CNY
Low
5,10 CNY
Mkt. cap
3,45 მლრდ.
Avg. vol.
10,62 მლნ.
Volume
8,21 მლნ.
52-wk high
11,23 CNY
52-wk low
5,03 CNY
EPS
-2,16 CNY
Shares outstanding
661,28 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
Profile
Xiangxue Pharmaceutical Co., Ltd. also known as XPH, is a Chinese pharmaceutical company. It was headquartered in Guangzhou Economic and Technological Development Zone, Guangzhou, the capital of the Guangdong Province. The company started in a place that near to the tourist spot Luogang Xiangxue, thus called itself Xiangxue. Xiangxue Pharmaceutical was a constituent of SZSE 200 Index, but was removed in January 2017; it was inserted to SZSE 700 Index instead at the same time. SZSE 200, 300 and 700 Indexes are subsets of SZSE 1000 Index, the latter is a stock market index for the top 1,000 companies by free-float adjusted capitalization. In July 2017 Xiangxue was also removed from SZSE Component Index, an index for top 500 companies of the exchange. Wikipedia
About Xiangxue Pharmaceutical Co Ltd
CEO-
Employees2,66 ათ.
Founded29 დეკ. 1997
Headquarters-
SectorPharmaceutical industry
Websitexphcn.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
327,92 მლნ.
449,49 მლნ.
354,16 მლნ.
348,62 მლნ.
Cost of goods sold
176,35 მლნ.
388,48 მლნ.
228,49 მლნ.
252,20 მლნ.
Cost of revenue
176,35 მლნ.
388,48 მლნ.
228,49 მლნ.
252,20 მლნ.
Research and development expenses
15,40 მლნ.
22,13 მლნ.
10,74 მლნ.
11,51 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
132,20 მლნ.
75,98 მლნ.
89,74 მლნ.
95,27 მლნ.
Operating expense
153,13 მლნ.
108,42 მლნ.
97,82 მლნ.
111,19 მლნ.
Total operating expenses
329,48 მლნ.
496,91 მლნ.
326,31 მლნ.
363,40 მლნ.
Operating income
-1,56 მლნ.
-47,41 მლნ.
27,85 მლნ.
-14,78 მლნ.
Other non operating income
302,00 ათ.
-14,25 მლნ.
-944,82 ათ.
-2,74 მლნ.
EBT including unusual items
-118,29 მლნ.
-1,00 მლრდ.
-89,20 მლნ.
-147,88 მლნ.
EBT excluding unusual items
-67,96 მლნ.
-144,93 მლნ.
-40,82 მლნ.
-81,08 მლნ.
Income tax expense
3,13 მლნ.
30,08 მლნ.
9,14 მლნ.
5,48 მლნ.
Effective tax rate
-2,65%
-3,00%
-10,25%
-3,70%
Other operating expenses
3,55 მლნ.
4,05 მლნ.
-3,18 მლნ.
-1,15 მლნ.
Net income
-128,03 მლნ.
-1,03 მლრდ.
-111,44 მლნ.
-157,38 მლნ.
Net profit margin
-39,04%
-229,21%
-31,47%
-45,14%
Earnings per share
-
-
-
-
Interest and investment income
-
175,82 ათ.
23,18 ათ.
15,53 ათ.
Interest expense
-66,70 მლნ.
-83,47 მლნ.
-67,75 მლნ.
-63,58 მლნ.
Net interest expenses
-66,70 მლნ.
-83,30 მლნ.
-67,73 მლნ.
-63,56 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
52,99 მლნ.
15,22 ათ.
75,28 მლნ.
37,21 მლნ.
Gain or loss from assets sale
932,06 ათ.
-8,92 მლნ.
-
-107,04 ათ.
AI content may include mistakes. Learn more
Google აპები